Abstract. Aspirin ingestion is a common precipitating factor of life-threatening asthma attacks, requiring some patients to undergo mechanical ventilation. The gene, d-tyrosyl-tRNA deacylase 1 (DTD1), may be a risk factor for aspirin-intolerant asthma (AIA) by catalyzing the hydrolysis of d-tryptophan and interacting with the tyrosyl-tRNA synthetase (tyrRS) enzyme, which promotes a pro-inflammatory phenotype. In order to investigate the association of DTD1 variants with the risk of AIA in an asthma cohort, 38 single nucleotide polymorphisms (SNPs) were genotyped and 5 major haplotypes were obtained in 163 AIA cases and 429 aspirin-tolerant asthma (ATA) controls. differences in DTD1 SNP and haplotype distributions were analyzed using logistic and multiple regression models and were adjusted for age, gender, smoking status, atopy and body mass index (BMI) as covariates. Subsequent analyses revealed no association between DTD1 variants and the risk of AIA. Although nominal evidence of an association was detected between several DTD1 variants and the rate of decline of the forced expiratory volume in the first second (FEV 1 ) in AIA patients (rs6136444, rs6136469, rs6081338 and DTD1_ht5; P=0.01-0.02), the signals reached the threshold of multiple testing corrections, suggesting that DTD1 variants do not affect the abnormalities of the upper airways in AIA patients.
Introduction
Aspirin-intolerant asthma (AIA) is the development of bronchoconstriction in asthmatic patients following the ingestion of aspirin, a non-steroidal anti-inflammatory drug (NSAID) (1, 2) , and is characterized by the triad of chronic rhinosinusitis, nasal polyps and exacerbated asthma akin to prolonged viral respiratory infection (2) . The prevalence rate of aspirin intolerance has been reported to be around 10-20% among adult asthmatics (3, 4) , with an observed predominance among women (5, 6) . A previous study has reported that 25% of asthma patients who required emergency mechanical ventilation are aspirin intolerant (7) , hence, ingestion of aspirin may be a precipitating factor in life-threatening asthma attacks (8) . However, despite the well-defined clinical characteristics of the disease, genetic underpinnings of AIA pathogenesis are still unclear.
The etiology of AIA development is attributable to the combinatorial effects of environmental and genetic risk factors. We have previously identified several variants in the solute carrier family 6 (neurotransmitter transporter, betaine/ GABA) member 12 (SLC6A12), the emilin/multimerin domain-containing protein 2 (EMID2) and the fibrous sheath interacting protein 1 (FSIP1) genes that are risk factors of AIA susceptibility (9) (10) (11) , suggesting that complex genetic mechanisms underlie AIA pathogenesis. Although candidate gene-association studies and genome-wide association studies (GWAS) have provided unprecedented insights into the triggers and pathophysiology of asthma, the exact functional mechanisms of AIA development are still unclear and the roles of numerous candidate genes still need to be elucidated. The human d-tyrosyl-tRNA deacylase 1 (DTD1) gene on chromosome 20p11.23 is a cellular component of the cytoplasm and is expressed mainly in the testis, ovary, spleen and in the adult and fetal brain (12) . The protein encoded by this gene interacts with tyrosyl-tRNA synthetase (tyrRS) by catalyzing the hydrolysis of d-tyrosyl-tRNA, thereby preventing the misacylated accumulation of metabolically inactive tRNA molecules including several d-amino acids such as d-tyrosine, d-aspartic acid and d-tryptophan (13, 14) . during the activation of cellular immune responses, interferon (IFN)-γ induces the enzyme indoleamine 2,3-dioxygenase (IdO), which catalyzes tryptophan into kynurenine and serotonin (15) , resulting in inhibition of T-cell proliferation (16) and increased severity of allergic asthma (17) . Elevated levels of serum kynurenine and serotonin in individuals with various degrees of chronic airway obstruction compared to non-asthmatic controls provide evidence that tryptophan may play a role in asthma pathogenesis (18) (19) (20) . In particular, inactivation or misregulation of the DTD1 gene, may hamper the recycling of misacylated tRNA molecules and lead to an increase in the toxicity of d-amino acids including tryptophan (21) .
Association analysis of DTD1 gene variations with aspirin-intolerance in asthmatics
With the crucial role of DTD1 in inhibiting the harmful effects of d-tryptophan accumulation as well as its association with the pro-inflammatory promoting tyrrS, we hypothesized that genetic variations in DTD1 may influence bronchial hypersensitivity in AIA patients. To elucidate the association between DTD1 variants and the risk of AIA, a case-control analysis was carried out in a korean population.
Materials and methods
Study subjects. Asthma patients were recruited from nine korean hospitals belonging to the Asthma Genome Research center, to serve as the primary subjects for our study. Each patient, as diagnosed by trained physicians, showed clinical symptoms that met the criteria for asthma according to the Global Initiative for Asthma (GINA) (22) . Evaluation of the subjects included dyspnea and wheezing during the past year plus one of the following: i) airway reversibility measured by a positive bronchodilator response of a >15% increase in the forced expiratory volume in the first second (FEV 1 ) or a >12% increase in FEV 1 plus 200 ml following inhalation of a short-acting bronchodilator; ii) airway hyperreactivity to <10 mg/ml Pc 20 methacholine; or iii) >20% increase in FEV 1 following 2 weeks of treatment with inhaled steroids and long-acting bronchodilators (23) . Twenty-four common inhalant allergens (e.g., dust mites, cat fur, dog fur, cockroaches, grasses, trees, ragweed pollen; Bencard co. Ltd., Brentford, Uk) were used in a skin-prick test. Total immunoglobulin E (IgE) was measured using the cAP system (Pharmacia diagnostics, Uppsala, Sweden). Atopy was defined as a wheal reaction ≥ to histamine or than 3 mm in diameter. Pulmonary function tests were performed using the Vmax Series 2130 Autobox Spirometer (SensorMedics, Yorba Linda, cA) with adherence to the American Thoracic Society (ATS) guidelines (24) . The reference values of lung functions used were according to the Morris-Polgar standards (25, 26) . All asthmatics underwent oral aspirin challenge (OAc) that was performed with increasing doses of aspirin (10-450 mg) (27,28) with modifications. the subjects reported no increase in asthma symptoms or respiratory tract infections within 6 weeks prior to the test. Briefly, patients with a history of aspirin hypersensitivity were given 30 mg and those having no history of aspirin hypersensitivity were initiated with 100 mg of aspirin orally. Symptoms, external signs (urticaria and angioedema) and FEV 1 were documented every 30 min for a period of 2 h. In the absence of any symptoms or signs suggestive of an adverse reaction after 2 h, 60 or 100 mg of aspirin was administered and the same measurements were repeated every 1 h, increasing the doses up to 450 mg until the patient developed a reaction. If no reaction occurred 5 h after the final dose, the test was deemed negative. changes in the FEV 1 were followed for 5 h after the final aspirin dose. Aspirin-induced bronchospasm, reflected by the rate (%) of decline in FEV 1 , was calculated as the pre-challenge FEV 1 minus the post-challenge FEV 1 divided by the pre-challenge FEV 1 . categorization of patients was based on individual oAc reactions. Asthmatics exhibiting ≥20% decrease in FEV 1 or a 15-19% decrease in FEV 1 with naso-ocular or cutaneous reactions were diagnosed as AIA cases, whereas those demonstrating <15% decrease in FEV 1 without naso-ocular or cutaneous reactions were identified as aspirin-tolerant asthma (ATA) controls. This study was undertaken with the understanding and written consent of each subject, and the protocols were approved by the Institutional Review Board of each hospital.
SNP genotyping and haplotype construction. candidate polymorphic SNPs of the DTD1 gene were selected and screened from the International hapMap Project (http://hapmap.ncbi. nlm.nih.gov/) based on the minor allele frequencies (MAF) in the Asian population (han chinese and Japanese), the linkage disequilibrium (Ld) status, and the importance of the position in the gene. Genomic dNA was extracted from peripheral blood lymphocytes using the Gentra Puregene kit (Gentra Systems, Minneapolis, MN) according to the manufacturer's protocol. SNP genotyping was performed using TaqMan assay (29) in the ABI PRISM 7900hT sequence detection system (Applied Biosystems, cA, USA). The genotyped data quality was assessed by duplicate dNA checking (n=10; rate of concordance in duplicates >99%). Using the Phase algorithm v.2.0 software (30), haplotypes were inferred from the successfully genotyped SNPs and those with a frequency >0.05 were included in the association analyses.
Statistical analyses.
The Ld between all pairs of biallelic loci were determined by Lewontin's d' (|D'|) and the Ld coefficient r 2 -values were examined using the haploview algorithm (31) . To determine the association between the DTD1 genotype distributions in AIA cases and ATA controls, the odds ratios and 95% confidence intervals as well as the corresponding P-values were calculated using logistic regression analysis controlling for age (continuous variable), gender (male=0, female=1), smoking status (non-smoker=0, ex-smoker=1, smoker=2), atopy (absence=0, presence=1) and body mass index (BMI) as covariates to eliminate or reduce any confounding variables that might influence the findings. data was managed and analyzed using the Statistical Analysis System (SAS) version 9.1 (SAS Inc., cary, Nc). In addition, the differences in the decline rate of FEV 1 following aspirin challenge among DTD1 genotypes and haplotypes were examined using regression analysis.
To achieve optimal correction for multiple testing of markers representing SNPs in Ld, the effective number of independent marker loci (29.1223) was calculated using the SNPSpd software (http://genepi.qimr.edu.au/general/daleN/SNPSpd/), a program that is based on the spectral decomposition (Spd) of matrices of pair-wise Ld between markers (32).
Results
Among a total of 592 asthmatics recruited in our study, 163 subjects were identified as AIA cases and 429 subjects were categorized as ATA controls based on the results of the aspirin provocation test. Table I . our findings also demonstrate a significant difference between the mean age of AIA patients (43.1 years) and that of the controls (47.3 years). In addition, results from the aspirin provocation test showed a significant increase in the aspirin-induced decline rate of FEV 1 in AIA patients compared to that of ATA controls (24.63% in AIA and 3.54% in ATA; P<0.0001). The predicted % FEV 1 , smoking status and Pc 20 methacholine values were significantly lower in AIA patients than in the AtA controls (P<0.05). Furthermore, the rates of nasal polyps in AIA patients (57.89%) were significantly higher compared to AtA controls (26.06), suggesting that aspirin-intolerance can elicit meaningful deficits in the upper airways. A positive history of aspirin hypersensitivity was also found to be significantly prevalent in AIA patients (51.92%) compared to ATA subjects (6.00%).
With an average call rate of 99.9%, 38 DTD1 SNPs were successfully genotyped in the asthma cohort of 592 korean patients; 1 SNP was localized in intron 2 and 1 in exon 6, 3 in intron 3, 25 in intron 4 and 8 SNPs were positioned in intron 5 ( Fig 1A and Table II) . Results from the hardy-Weinberg equilibrium (HWE) test showed no significant differences between the distribution of the observed genotypes and the expected distributions (P>0.05; Table II ). The MAF of each SNP is shown in Table II . Using the genotyped SNPs, five major haplotypes with frequencies >0.05 (Fig. 1B) were obtained and included in the association analyses. The haplotypes were contained in one Ld block (Fig. 1c) that was established from pair-wise comparisons of the 38 genotyped SNPs.
Results from logistic analyses showed no significant association between DTD1 variants and the risk of AIA in a Korean population (table III) . Since the decline rate of FEV 1 induced by aspirin provocation is an important diagnostic marker of AIA, further association analysis with the DTD1 genetic variants was performed using a regression model. Initial results revealed significant associations between three DTD1 SNPs (rs6136444, rs6136469 and rs6081338) and the decline rate of FEV 1 via a recessive model of genetic inheritance (P=0.01-0.02; table IV), whereas one haplotype (DTD1_ht5) was also significantly associated with the decline rate of FEV 1 via co-dominant and dominant mechanisms (P=0.02; table IV). However, with 29.1223 as the effective number of independent marker loci, the significant values were not retained after multiple testing corrections.
Discussion
The development of AIA can be attributed to combinatorial effects of genetic and environmental factors. In some patients, aspirin-intolerance is manifested through severe acute asthma attacks requiring hospital admission and mechanical ventilation to support the failing lungs (7, 8) . Once developed, AIA cases are considered fatal despite treatment with fastacting medicines and avoidance of aspirin. As a precipitating factor in life-threatening asthma attacks, researchers are now actively engaged in identifying mechanisms involved in the development of AIA that may lead to novel targets for treatment of the disease. despite previous reports on genetic markers of bronchial hypersensitivity as a result of aspirin intake, the exact mechanisms of the disease are still unclear and susceptibility genes still need to be identified. Findings from this study may contribute to the current knowledge of AIA pathogenesis. Although d-amino acids are thought to not be incorporated in proteins, several aminoacyl-tRNA synthetases (aaRSs) such as the tyrRS are capable of transferring the d-isomer of their amino acid onto their cognate tRNA, resulting in accumulation of the metabolically inactive d-aminoacyl-tRNAs (21) . The DTD1 gene counters this process and interacts with tyrRS by possessing a d-tyrosyl-tRNA deacylase that cleaves the ester bond between a tRNA molecule and a d-amino acid (21) . Misregulation of DTD1 gene expression may increase the toxicity of d-amino acids such as d-tryptophan, an enzyme that has been implicated in AIA etiology by producing kynurenine and serotonin (18) (19) (20) . Furthermore, Wakasugi and Schimmel have revealed that cytoplasmic tyrRS has proinflammatory cytokine functions similar to interleukin-8 (IL-8) and to the endothelial monocyte-activating polypeptide II (EMAP II) (33) . Previous studies have demonstrated the association between an IL-8 polymorphism and respiratory syncytial virus (rSV) bronchiolitis, a condition that may progress to bronchial asthma (34, 35) . In addition, IL-8 has been implicated in neutrophilic inflammation associated with severe asthma (36, 37) , whereas EMAP II has been known to stimulate the production of tumor necrosis factor-α (TNFα) (38) , an AIA-susceptibility gene (39) . Given the indirect role of DTD1 in AIA susceptibility by interacting with tyrRS and catalyzing the formation of d-amino acids, we investigated the association of DTD1 genetic variants with the risk of AIA in a korean population.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
In this study, differences in the distributions of 38 genotyped SNPs and 5 major haplotypes in DTD1 were analyzed for a possible association with the risk of AIA and decline rate of FEV 1 . Results from the logistic regression analysis revealed a lack of association between DTD1 variants and AIA susceptibility. Furthermore, since the decline rate of FEV 1 is a crucial diagnostic marker for AIA, further analysis was performed. our initial findings revealed associations of several DTD1 SNPs (rs6136444, rs6136469 and rs6081338) and of one haplotype (DTD1_ht5) with the decline rate of FEV 1 induced by aspirin provocation. Patients with the rare allele (R/R genotype) of the polymorphisms were in greater risk of developing AIA compared to subjects having other genotypes (c/c and c/r). However, the significant signals were not retained after multiple testing corrections, suggesting that DTD1 polymorphisms do not affect pulmonary function abnormalities in AIA patients.
Although the exact molecular mechanisms are not clear, the DTD1 gene can counteract the accumulation of inactive tRNA molecules (14) and promote defense mechanisms against the harmful effects of d-amino acids including tryptophan, an enzyme that is down-regulated by aspirin (40) and has been implicated in AIA susceptibility in several studies (18) (19) (20) . The small sample size (n=592) may serve as a potential limitation to this preliminary study, and therefore, in order to clarify the relationship between DTD1 variants and the risk of AIA with high statistical power, further replication studies should use larger scale samples in various ethnic groups (n>1,000).
to our knowledge, this study is the first to explore the relationship between DTD1 gene variations and AIA pathogenesis. to conclude, our findings provide evidence that DTD1 variants do not influence AIA and the decline rate of FEV 1 in a korean population. however, considering the important function of DTD1 in AIA pathogenesis, future replication studies in a larger cohort are recommended. These studies may be useful in the current genetic etiology of AIA susceptibility.
